Daraxonrasib
(da-RAK-son-RAS-ib)
This page contains brief information about daraxonrasib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Rasonque
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Daraxonrasib is approved to treat:
- pancreatic cancer in adults whose cancer has spread and has been treated with at least one type of systemic therapy or who cannot receive combination systemic therapy
More About Daraxonrasib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Targeted Therapy to Treat Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Daraxonrasib - Check for trials from NCI's list of cancer clinical trials now accepting patients.